These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25864571)

  • 1. Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials.
    Thompson DD; Murray GD; Candelise L; Chen Z; Sandercock PA; Whiteley WN
    Int J Stroke; 2015 Oct; 10(7):1024-30. PubMed ID: 25864571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.
    Whiteley WN; Adams HP; Bath PM; Berge E; Sandset PM; Dennis M; Murray GD; Wong KS; Sandercock PA
    Lancet Neurol; 2013 Jun; 12(6):539-45. PubMed ID: 23642343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.
    Whiteley WN; Thompson D; Murray G; Cohen G; Lindley RI; Wardlaw J; Sandercock P;
    Stroke; 2014 Apr; 45(4):1000-6. PubMed ID: 24603072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
    Chen ZM; Sandercock P; Pan HC; Counsell C; Collins R; Liu LS; Xie JX; Warlow C; Peto R
    Stroke; 2000 Jun; 31(6):1240-9. PubMed ID: 10835439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.
    Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB;
    Trials; 2010 May; 11():51. PubMed ID: 20459856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.
    Kim BJ; Lee EJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kang DW;
    Lancet Neurol; 2018 Jun; 17(6):509-518. PubMed ID: 29778364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
    Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD
    Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
    Ciccone A; Motto C; Abraha I; Cozzolino F; Santilli I
    Cochrane Database Syst Rev; 2014 Mar; (3):CD005208. PubMed ID: 24609741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.
    Emberson J; Lees KR; Lyden P; Blackwell L; Albers G; Bluhmki E; Brott T; Cohen G; Davis S; Donnan G; Grotta J; Howard G; Kaste M; Koga M; von Kummer R; Lansberg M; Lindley RI; Murray G; Olivot JM; Parsons M; Tilley B; Toni D; Toyoda K; Wahlgren N; Wardlaw J; Whiteley W; del Zoppo GJ; Baigent C; Sandercock P; Hacke W;
    Lancet; 2014 Nov; 384(9958):1929-35. PubMed ID: 25106063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
    Hong KS; Kim BJ; Lee JY; Kwon SU;
    Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
    ; Baigent C; Blackwell L; Collins R; Emberson J; Godwin J; Peto R; Buring J; Hennekens C; Kearney P; Meade T; Patrono C; Roncaglioni MC; Zanchetti A
    Lancet; 2009 May; 373(9678):1849-60. PubMed ID: 19482214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
    Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
    JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin or heparin in acute stroke.
    Pereira AC; Brown MM
    Br Med Bull; 2000; 56(2):413-21. PubMed ID: 11092090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visible infarction on computed tomography is an independent predictor of poor functional outcome after stroke, and not of haemorrhagic transformation.
    Wardlaw JM; West TM; Sandercock PA; Lewis SC; Mielke O;
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):452-8. PubMed ID: 12640062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives on the pharmacotherapy of ischemic stroke.
    Bradberry JC; Fagan SC; Gray DR; Moon YS
    J Am Pharm Assoc (2003); 2004; 44(2 Suppl 1):S46-56; quiz S56-7. PubMed ID: 15095935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.